429 Development of extracellular signal-regulated kinase 5 (ERK5) inhibitors for anti-cancer therapy
Myers, S., Martin, N., Bawn, R., Blackburn, T., Barrett, L., Reuillon, T., Golding, B., Griffin, R., Hammonds, T., Hardcastle, I., Leung, H., Newell, D., Rigoreau, L., Wong, A., Cano, C.Том:
50
Мова:
english
Журнал:
European Journal of Cancer
DOI:
10.1016/S0959-8049(14)70555-6
Date:
November, 2014
Файл:
PDF, 92 KB
english, 2014